project id: TCGA-LUAD; case submitter id: TCGA-93-A4JP; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.18; age at index: 64; days to birth: -23620; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1948; age at diagnosis: 23620; ajcc pathologic m: M1b; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 578.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; composition: Not Reported; days to sample procurement: 0; initial weight: 450.0; portion submitter id: TCGA-93-A4JP-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 5.0; percent stromal cells: 30.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;